Yıl: 2015 Cilt: 16 Sayı: 3 Sayfa Aralığı: 205 - 211 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Validation of Turkish version of Premenstrual Symptoms Impact Survey (PMSIS ) for assessing status of premenstrual syndrome in women of reproductive age

Öz:
Amaç: Adet Öncesi Ş ikayetler Etki Ölçeği (Premenstrual Symptoms Impact Survey [PMSIS ]) Türkçe sürümünün geçerlilik ve güvenilirliğinin araştırılması amaçlandı. Bu ölçek, altı soru ile premenstrüel sendromun (PMS),bireyin işlevsel sağlık ve iyilik durumu üzerine etkisini ölçümleyebilmektedir. Yöntem: İngilizce olan PMSIS ninTürkçeye bağımsız olarak çevrildikten sonra geri çeviri yöntemi ile adaptasyonu yapıldı. Yıllık sağlıklı kadın jinekolojik muayenesi ile sağlıklı bulunan ve üreme döneminde olan 63 kadın üzerinden ölçeğin geçerliliği ve güvenilirliğiincelendi. Türkçe bir ölçek olan Premenstrüel Sendrom Ölçeği (PMSÖ), PMSIS in eş zamanlı geçerliliğini belirle-mek için kullanıldı. Ölçek verilerinin analizinde içerik geçerliliği, test-tekrar test güvenilirliği, Cronbach alfa, eşzamanlı geçerlilik ve yapı geçerliliği testleri uygulandı. Bulgular: Ölçeğin içerik geçerliliği yüksek (%91) bulundu.Güvenilirlik analizleri sonucunda, PMSIS in birinci ve ikinci uygulamalarının puanları arasında sınıf-içi korelasyondeğeri 0.70 bulundu ve ölçeğin test ve tekrar-test sonuçları iyi uyumlu olarak yorumlandı; ayrıca Cronbach alfadeğeri 0.89 bulundu ve iç tutarlılığı yeterli ve yüksek olarak yorumlandı. Eş zamanlı geçerlilik analizleri sonucunda,PMSIS in birinci uygulaması ve PMSÖ uygulaması puanlarının Pearson korelasyon katsayısı 0.70 bulundu. Yapıgeçerliliği analizi için yapılan faktör analizi, özgün ölçekte olduğu gibi tüm maddelerin tek boyutta toplandığını, faktöryüklerinin 0.74-0.84 arasında değiştiğini ve toplam varyansın %65.1 olduğunu gösterdi. PMSIS ölçeğinin eşzamanlı ve yapısal geçerlilikleri iyi olarak yorumlandı. Sonuçlar: PMSIS in Türkçe sürümü, iyi geçerlilik ve güveni-lirlik özelliklerine sahiptir. Ölçek güvenilir, tutarlı ve geçerli bir ölçek olarak üreme dönemindeki kadınlarda PMSdurumunu ve PMS tedavisinin sonuçlarını Türk toplumunda değerlendirebilir.
Anahtar Kelime:

Konular: Psikiyatri

Üreme dönemindeki kadınlarda premenstrüel sendrom durumunun değerlendirilmesinde Adet Öncesi Şikayetler Etki Ölçeği Türkçe sürümünün geçerliliği

Öz:
Objective: We aimed to evaluate the reliability and validity of a Turkish adaptation of the Premenstrual SymptomsImpact Survey (PMSIS ), a six-question health survey that measures the impact of symptoms of premenstrualsyndrome (PMS) on an individual s functional health and well-being. Methods: The PMSIS was independentlytranslated into Turkish and its adaptation to Turkish language was performed via back-translation. The reliabilityand validity of the PMSIS were examined with 63 women of reproductive age, found healthy during annual well- woman gynecologic examination. Premenstrual Syndrome Scale (PMSS), a Turkish questionnaire, was adminis- tered to assess the concurrent validity of the PMSIS . For the assessment of survey data, the content validity,test-retest reliability, Cronbach s alpha, concurrent validity, and construct validity tests were used. Results: Thecontent validity index of the Turkish version of PMSIS was found as high (91%). After reliability analyses, theintra-class correlation coefficient between the PMSIS scores at the first and second assessments was 0.70,showing a good agreement between test and retest values; and the Cronbach s alpha coefficient was 0.89, indi- cating adequate and high internal consistency. Regarding the concurrent validity, the Pearson's correlation coeffi- cient between the PMSIS (first assessment) and PMSS scores was 0.70. Regarding the construct validity, factoranalysis revealed that one dimension was found; and factor loading of items ranged from 0.74 t0 0.84 and totalvariant of scale was expressed as 65.1%. The PMSIS had a good concurrent and construct validities. Conc- lusions: The Turkish version of PMSIS has good reliability and validity properties. It is a reliable, consistent, andvalid instrument to assess the status of PMS in women of reproductive age and the outcome of PMS treatment inTurkish population.
Anahtar Kelime:

Konular: Psikiyatri
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Matsumoto T, Asakura H, Hayashi T. Biopsycho- social aspects of premenstrual syndrome and premenstrual dysphoric disorder. Gynecol Endocrinol 2013;29:67-73
  • 2. RCOG. The Royal College of Obstetricians and Gynaecologists. Green-top Guideline No. 48. Management of Premenstrual Syndrome, December 2007. Available at: http://www.rcog.org.uk/womens- health/clinical-guidance/management- premenstrual-syndrome-green-top-48 (accessed in September 2014).
  • 3. EMA. European Medicines Agency. Committee for Medicinal Products for Human Use. Guideline on the treatment of Premenstrual Dysphoric Disorder (PMDD). 2010. Available at: http://www.emea.europa.eu/docs/en_GB/docume nt_library/Scientific_guideline/2010/05/WC50009 0882.pdf (accessed in September 2014).
  • 4. Borenstein JE, Dean BB, Yonkers KA, Endicott J. Using the daily record of severity of problems as a screening instrument for premenstrual syndrome. Obstet Gynecol 2007:109;1068-1075.
  • 5. Craner J, Sigmon S, Martinson A, McGillicuddy M. Perceptions of health and somatic sensations in women reporting premenstrual syndrome and premenstrual dysphoric disorder. J Nerv Ment Dis 2013; 201:780-785.
  • 6. Epperson CN, Steiner M, Hartlage SA, Eriksson E, Schmidt PJ, Jones I, et al. Premenstrual dysphoric disorder: evidence for a new category for DSM-5. Am J Psychiatry 2012; 169:465-475.
  • 7. Hartlage SA, Breaux CA, Yonkers KA. Addressing concerns about the inclusion of premenstrual dysphoric disorder in DSM-5. J Clin Psychiatry 2014; 75(1):70-76.
  • 8. Wallenstein GV, Blaisdell-Gross B, Gajria K, Guo A, Hagan M, Kornstein SG, et al. Development and validation of the Premenstrual Symptoms Impact Survey (PMSIS): a disease-specific quality of life assessment tool. J Womens Health (Larchmt) 2008; 17:439-450.
  • 9. Pierce AG. Measurement. A Talbot (Ed.), Princi- ples and Practice of Nursing Research, St. Louis: Mosby, 1995, p.265-291.
  • 10. Corson MA, Boyd T, Kind P, Allen PF, Steele JG. Measuring oral health: does your treatment really make a difference. Br Dent J 1999; 187:481-484.
  • 11. Tavakol M, Dennick R. Making sense of Cronbach’s alpha. Int J Med Educ 2011; 2:53-55.
  • 12. Gencdogan B. Premenstruel sendrom icin yeni bir olcek [A New Scale for Premenstrual Syndrome]. Türkiye'de Psikiyatri 2006;8:81-7. Available at: http://www.psikiyatridizini.org/viewarticle.php?arti cle_id=5131 (accessed in September 2014).
  • 13. Netemeyer RG, Bearden WO, Sharma S. Scaling Procedures: Issue and Applications. California: Sage Publications, 2003.
  • 14. DeVellis RF. Scale Development: Theory and Applications. Second ed., Thousand Oaks, CA: Sage Publications, 2003. Cerny BA, Kaiser HF. Study of a measure of sampling adequacy for factor-analytic correlation matrices. Multivariate Behav Res 1977; 12:43-47.
  • 15. Moos RH. The development of a menstrual distress questionnaire. Psychosom Med 1968; 30:853-867.
  • 16. Haywood A, Slade P, King H. Assessing the assessment measures for menstrual cycle symp- toms: a guide for researchers and clinicians. J Psychosom Res 2002; 52:223-237.
  • 17. CDC. Centers for Disease Control and Prevention. Health Related Quality of Life-14. 2013. Available at: http://www.cdc.gov/hrqol/hrqol14_measure.htm (accessed in September 2014).
  • 18. Halbreich U, Borenstein J, Pearlstein T, Kahn LS. The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD). Psychoneuroendocrinology 2003; 28(Suppl.3):1- 23.
  • 19. Dereboy C, Dereboy IF, Yigitol F, Coskun A. Premenstruel Degerlendirme Formunun psiko- metrik verileri: Küme analitik bir çalısma [Psycho- metric Data for the Premenstrual Assessment Form: A Cluster Analytic Study]. Türk Psikiyatri Dergisi 1994; 5:83-90. Available at: http://www.turkpsikiyatri.com/default.aspx?modul =ingilizceOzet&gFPrkMakale=281 (accessed in September 2014).
  • 20. Halbreich U, Endicott J, Schacht S, Nee J. The diversity of premenstrual changes as reflected in the Premenstrual Assessment Form. Acta Psychiatr Scand 1982; 65:46-65.
  • 21. Erbil N, Karaca A, Kiris T. Investigation of pre- menstrual syndrome and contributing factors among university students. Turk J Med Sci 2010; 40:565-573. Available at: http://journals.tubitak.gov.tr/medical/issues/sag- 10-40-4/sag-40-4-9-0812-2.pdf (accessed in September 2014).
  • 22. Yang M, Gricar JA, Maruish ME, Hagan MA, Kornstein SG, Wallenstein GV. Interpreting Pre- menstrual Symptoms Impact Survey scores using outcomes in health-related quality of life and sexual drive impact. J Reprod Med 2010; 55(1- 2):41-48.
APA GÜLER Ö, ATAÇAĞ T, yayci e, ÇETIN A, ÇETİN M (2015). Validation of Turkish version of Premenstrual Symptoms Impact Survey (PMSIS ) for assessing status of premenstrual syndrome in women of reproductive age. , 205 - 211.
Chicago GÜLER ÖMER TOLGA,ATAÇAĞ Tijen,yayci eyup,ÇETIN ALI,ÇETİN Meral Validation of Turkish version of Premenstrual Symptoms Impact Survey (PMSIS ) for assessing status of premenstrual syndrome in women of reproductive age. (2015): 205 - 211.
MLA GÜLER ÖMER TOLGA,ATAÇAĞ Tijen,yayci eyup,ÇETIN ALI,ÇETİN Meral Validation of Turkish version of Premenstrual Symptoms Impact Survey (PMSIS ) for assessing status of premenstrual syndrome in women of reproductive age. , 2015, ss.205 - 211.
AMA GÜLER Ö,ATAÇAĞ T,yayci e,ÇETIN A,ÇETİN M Validation of Turkish version of Premenstrual Symptoms Impact Survey (PMSIS ) for assessing status of premenstrual syndrome in women of reproductive age. . 2015; 205 - 211.
Vancouver GÜLER Ö,ATAÇAĞ T,yayci e,ÇETIN A,ÇETİN M Validation of Turkish version of Premenstrual Symptoms Impact Survey (PMSIS ) for assessing status of premenstrual syndrome in women of reproductive age. . 2015; 205 - 211.
IEEE GÜLER Ö,ATAÇAĞ T,yayci e,ÇETIN A,ÇETİN M "Validation of Turkish version of Premenstrual Symptoms Impact Survey (PMSIS ) for assessing status of premenstrual syndrome in women of reproductive age." , ss.205 - 211, 2015.
ISNAD GÜLER, ÖMER TOLGA vd. "Validation of Turkish version of Premenstrual Symptoms Impact Survey (PMSIS ) for assessing status of premenstrual syndrome in women of reproductive age". (2015), 205-211.
APA GÜLER Ö, ATAÇAĞ T, yayci e, ÇETIN A, ÇETİN M (2015). Validation of Turkish version of Premenstrual Symptoms Impact Survey (PMSIS ) for assessing status of premenstrual syndrome in women of reproductive age. Anadolu Psikiyatri Dergisi, 16(3), 205 - 211.
Chicago GÜLER ÖMER TOLGA,ATAÇAĞ Tijen,yayci eyup,ÇETIN ALI,ÇETİN Meral Validation of Turkish version of Premenstrual Symptoms Impact Survey (PMSIS ) for assessing status of premenstrual syndrome in women of reproductive age. Anadolu Psikiyatri Dergisi 16, no.3 (2015): 205 - 211.
MLA GÜLER ÖMER TOLGA,ATAÇAĞ Tijen,yayci eyup,ÇETIN ALI,ÇETİN Meral Validation of Turkish version of Premenstrual Symptoms Impact Survey (PMSIS ) for assessing status of premenstrual syndrome in women of reproductive age. Anadolu Psikiyatri Dergisi, vol.16, no.3, 2015, ss.205 - 211.
AMA GÜLER Ö,ATAÇAĞ T,yayci e,ÇETIN A,ÇETİN M Validation of Turkish version of Premenstrual Symptoms Impact Survey (PMSIS ) for assessing status of premenstrual syndrome in women of reproductive age. Anadolu Psikiyatri Dergisi. 2015; 16(3): 205 - 211.
Vancouver GÜLER Ö,ATAÇAĞ T,yayci e,ÇETIN A,ÇETİN M Validation of Turkish version of Premenstrual Symptoms Impact Survey (PMSIS ) for assessing status of premenstrual syndrome in women of reproductive age. Anadolu Psikiyatri Dergisi. 2015; 16(3): 205 - 211.
IEEE GÜLER Ö,ATAÇAĞ T,yayci e,ÇETIN A,ÇETİN M "Validation of Turkish version of Premenstrual Symptoms Impact Survey (PMSIS ) for assessing status of premenstrual syndrome in women of reproductive age." Anadolu Psikiyatri Dergisi, 16, ss.205 - 211, 2015.
ISNAD GÜLER, ÖMER TOLGA vd. "Validation of Turkish version of Premenstrual Symptoms Impact Survey (PMSIS ) for assessing status of premenstrual syndrome in women of reproductive age". Anadolu Psikiyatri Dergisi 16/3 (2015), 205-211.